MERZ NORTH AMERICA INC has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in Republic of Korea, United States and Brazil. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and medical technology are FISCHER OHG ARZNEIMITTELWERK, CHENGDU GUOHONG PHARMACEUTICAL CO LTD and ARBUTUS BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 4 | |
#2 | United States | 3 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Mexico | 2 | |
#7 | Australia | 1 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 | |
#10 | Taiwan | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Kvalnes Kalla Lynn | 11 |
#2 | Delong Mitchell A | 11 |
#3 | Boissy Raymond | 6 |
#4 | Witwit Moe | 5 |
#5 | Ewell Kevin R | 5 |
#6 | Chambournier Gilles | 5 |
#7 | Devore Dale | 4 |
#8 | Voigts Robert | 4 |
#9 | Kalla Lynn Kvalnes | 2 |
#10 | Mitchell A Delong | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020247469A1 | Methods and compositions for treating undesired implanted tissue filler | |
US2019269721A1 | Methods and compositions for degrading calcium phosphate and for treating calcification disorders | |
US2013224136A1 | Chiral compounds, compositions, products and methods employing same |